Comparative risk of high-grade histopathology diagnosis after a CIN 1 finding in endocervical curettage versus cervical biopsy

Journal of Lower Genital Tract Disease

Volumn 17, Issue 2, 2013, Pages 137-141

  Gage, Julia C ^a   Duggan, Máire A ^b   Nation, Jill G ^c   Gao, Song ^d   Castle, Philip E ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Department of Pathology and Laboratory Medicine ^*  (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d Alberta Cancer Board   (Canada)

^e American Society for Clinical Pathology   (United States)

Author keywords

Cervical intraepithelial neoplasia; Colposcopy; Curettage; Diagnosis; Endocervical sampling

Indexed keywords

ADULT; ARTICLE; CANCER RISK; COLPOSCOPY; ENDOCERVICAL CURETTAGE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; CURETTAGE; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; MIDDLE AGED; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84876121681     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3182630c41     Document Type: Article

References (7)

1. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis 2007; 11: 223-39.
2. Gage JC, Duggan MA, Nation JG, Gao S, Castle PE. Detection of cervical cancer and its precursors by endocervical curettage in 13,115 colposcopically guided biopsy examinations. Am J Obstet Gynecol2010;203: 481.e1-9.
3. ShermanME,WangSS,TaroneR, RichL, Schiffman M. Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias. Cancer Epidemiol Biomarkers Prev2003;12: 372-9.
4. Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasiagrade 2.Obstet Gynecol2009;113: 18-25.
5. Castle PE, SideriM, Jeronimo J, Solomon D, Schiffman M. Risk assessment to guide the prevention of cervical cancer. J Low Genit Tract Dis 2008;12: 1-7.
6. Spirtos NM, Schlaerth JB, d'Ablaing G 3rd, Morrow CP. A critical evaluation of the endocervical curettage. Obstet Gynecol 1987;70: 729-33.
7. ZahnCM,Rao LK,OlsenC,WhitworthSA,Washington A, Crothers BA.Reproducibility of endocervical curettage diagnoses. Obstet Gynecol2011;118(2 Pt 1): 240-8.